Pharma BD Deal Intelligence
AstraZeneca PLC / Modella AI, Inc.
2026 · Acquisition/Merger · Complete
AstraZeneca acquired Modella AI, a developer of multi-modal foundation models and AI agents for oncology research, to embed the technology directly in AstraZeneca's oncology R&D environment. The acquisition followed a multi-year collaboration between the two companies announced in July 2025. Financial terms were not disclosed.
This deal is too recent to grade. Critic Score and Outcome Score are assigned after the announcement-week coverage settles and, for Outcome, after the 5-year post-close assessment window opens — expected 2031 at the earliest for this deal, once/if it closes.
Key facts
- Announced Jan 13, 2026
- Deal type Acquisition/Merger
Related deals
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals
More: 2026 deals · AstraZeneca PLC deals